Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Conditions: Advanced Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Cetuximab; Other: Questionnaire Administration Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Conditions: Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Cetuximab; Other: Questionnaire Administration Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Conditions: Advanced Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Cetuximab; Other: Questionnaire Administration Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Conditions: Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Cetuximab; Other: Questionnaire Administration Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Conditions: Advanced Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Cetuximab; Other: Questionnaire Administration Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas Involving the Bone, the PROSPER Study
Conditions: Bone Sarcoma; Chondrosarcoma; Chordoma; Ewing Sarcoma of Bone; Pelvic Rhabdomyosarcoma Interventions: Other: Electronic Health Record Review; Other: Quality-of-Life Assessment Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2021 Category: Research Source Type: clinical trials